Yen FS - Search Results

1

Comment on Yang et al. GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease. Diabetes Care 2022;45:1184-1192.

Hung CH, Yen FS, Wei JC. Hung CH, et al. Among authors: yen fs. Diabetes Care. 2022 Dec 1;45(12):e181. doi: 10.2337/dc22-0701. Diabetes Care. 2022. PMID: 36455119 No abstract available.

2

Cardiovascular outcomes of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes on insulin therapy.

Yen FS, Chiang JH, Pan CW, Lin BJ, Wei JC, Hsu CC. Yen FS, et al. Diabetes Res Clin Pract. 2018 Jun;140:279-287. doi: 10.1016/j.diabres.2018.04.012. Epub 2018 Apr 12. Diabetes Res Clin Pract. 2018. PMID: 29654814

3

Effects of metformin use on total mortality in patients with type 2 diabetes and chronic obstructive pulmonary disease: A matched-subject design.

Yen FS, Chen W, Wei JC, Hsu CC, Hwu CM. Yen FS, et al. PLoS One. 2018 Oct 4;13(10):e0204859. doi: 10.1371/journal.pone.0204859. eCollection 2018. PLoS One. 2018. PMID: 30286138 Free PMC article.

4

All-cause mortality of insulin plus dipeptidyl peptidase-4 inhibitors in persons with type 2 diabetes.

Yen FS, Chiang JH, Hwu CM, Yen YH, Lin BJ, Wei JC, Hsu CC. Yen FS, et al. Among authors: yen yh. BMC Endocr Disord. 2019 Jan 5;19(1):3. doi: 10.1186/s12902-018-0330-7. BMC Endocr Disord. 2019. PMID: 30611254 Free PMC article.

5

Pioglitazone Exposure Reduced the Risk of All-Cause Mortality in Insulin-Treated Patients with Type 2 Diabetes Mellitus.

Yen FS, Wang HC, Pan CW, Wei JC, Hsu CC, Hwu CM. Yen FS, et al. J Clin Endocrinol Metab. 2020 Mar 1;105(3):dgz026. doi: 10.1210/clinem/dgz026. J Clin Endocrinol Metab. 2020. PMID: 31544207

6

Urate-Lowering Therapy May Prevent the Development of Coronary Artery Disease in Patients With Gout.

Yen FS, Hsu CC, Li HL, Wei JC, Hwu CM. Yen FS, et al. Front Med (Lausanne). 2020 Feb 27;7:63. doi: 10.3389/fmed.2020.00063. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32175324 Free PMC article.

7

Urate-lowering therapy exerts protective effects against hypertension development in patients with gout.

Lin KH, Yen FS, Li HL, Wei JC, Hsu CC, Yang CC, Hwu CM. Lin KH, et al. Among authors: yen fs. J Hum Hypertens. 2021 Apr;35(4):351-359. doi: 10.1038/s41371-020-0342-4. Epub 2020 May 4. J Hum Hypertens. 2021. PMID: 32366929

8

Persons with type 2 diabetes and high insulin persistence were associated with a lower risk of mortality: A nationwide retrospective cohort study.

Yen FS, Wei JC, Liu JS, Hsu CC, Hwu CM. Yen FS, et al. J Diabetes Investig. 2021 Feb;12(2):146-154. doi: 10.1111/jdi.13330. Epub 2020 Jul 25. J Diabetes Investig. 2021. PMID: 32569417 Free PMC article.

9

Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with gout.

Yen FS, Hsu CC, Li HL, Wei JC, Hwu CM. Yen FS, et al. PLoS One. 2020 Jun 23;15(6):e0234909. doi: 10.1371/journal.pone.0234909. eCollection 2020. PLoS One. 2020. PMID: 32574194 Free PMC article.

10

Respiratory outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease.

Yen FS, Wei JC, Yang YC, Hsu CC, Hwu CM. Yen FS, et al. Sci Rep. 2020 Jun 24;10(1):10298. doi: 10.1038/s41598-020-67338-2. Sci Rep. 2020. PMID: 32581289 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters